Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “etodolac”

4 pharma patents match "etodolac" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "etodolac" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “etodolac” · 30,257 patents in full index Clear search

  1. US 7211599

    Use of etodolac to treat hyperplasia

    The Regents of the University of California · Granted May 1, 2007 · Expires Apr 26, 2027

    granted

  2. US 7105560

    Use of etodolac in the treatment of multiple myeloma

    The Regents of the University of California · Granted Sep 12, 2006 · Expires Sep 7, 2026

    granted

  3. US 7105561

    Use of etodolac for the treatment of prostate cancer

    The Regents of the University of California · Granted Sep 12, 2006 · Expires Sep 7, 2026

    granted

  4. US 6545034

    Use of etodolac for the treatment of chronic lymphocytic leukemia

    The Regents of the University of California · Granted Apr 8, 2003 · Expires Apr 3, 2023

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.